Oh PI - Search Results

1

Cytochrome P450-soluble epoxide hydrolase oxylipins, depression and cognition in type 2 diabetes.

Anita NZ, Herrmann N, Ryoo SW, Major-Orfao C, Lin WZ, Kwan F, Noor S, Rabin JS, Marzolini S, Nestor S, Ruthirakuhan MT, MacIntosh BJ, Goubran M, Yang P, Cogo-Moreira H, Rapoport M, Gallagher D, Black SE, Goldstein BI, Lanctôt KL, Oh PI, Taha AY, Swardfager W. Anita NZ, et al. Among authors: oh pi. J Diabetes Complications. 2024 Sep;38(9):108826. doi: 10.1016/j.jdiacomp.2024.108826. Epub 2024 Jul 22. J Diabetes Complications. 2024. PMID: 39059187 Free article.

2

Efficacy and safety of neuroleptics in behavioral disorders associated with dementia.

Lanctôt KL, Best TS, Mittmann N, Liu BA, Oh PI, Einarson TR, Naranjo CA. Lanctôt KL, et al. Among authors: oh pi. J Clin Psychiatry. 1998 Oct;59(10):550-61; quiz 562-3. doi: 10.4088/jcp.v59n1010. J Clin Psychiatry. 1998. PMID: 9818639

3

Pharmacoeconomic evaluation of clozapine in treatment-resistant schizophrenia: a cost-utility analysis.

Oh PI, Iskedjian M, Addis A, Lanctôt K, Einarson TR. Oh PI, et al. Can J Clin Pharmacol. 2001 Winter;8(4):199-206. Can J Clin Pharmacol. 2001. PMID: 11743592

4

Utility scores of symptom profiles in major depression.

Schaffer A, Levitt AJ, Hershkop SK, Oh P, MacDonald C, Lanctot K. Schaffer A, et al. Psychiatry Res. 2002 Jun 1;110(2):189-97. doi: 10.1016/s0165-1781(02)00097-5. Psychiatry Res. 2002. PMID: 12057830

5

Palivizumab prophylaxis for respiratory syncytial virus in Canada: utilization and outcomes.

Oh PI, Lanctôt KL, Yoon A, Lee DS, Paes BA, Simmons BS, Parison D, Manzi P; Composs Investigators. Oh PI, et al. Pediatr Infect Dis J. 2002 Jun;21(6):512-8. doi: 10.1097/00006454-200206000-00007. Pediatr Infect Dis J. 2002. PMID: 12182374 Clinical Trial.

6

The cost-benefit of cholinesterase inhibitors in mild to moderate dementia: a willingness-to-pay approach.

Wu G, Lanctôt KL, Herrmann N, Moosa S, Oh PI. Wu G, et al. Among authors: oh pi. CNS Drugs. 2003;17(14):1045-57. doi: 10.2165/00023210-200317140-00004. CNS Drugs. 2003. PMID: 14594444

7

Relationship between cardiopulmonary fitness and depressive symptoms in cardiac rehabilitation patients with coronary artery disease.

Swardfager W, Herrmann N, Dowlati Y, Oh P, Kiss A, Lanctôt KL. Swardfager W, et al. J Rehabil Med. 2008 Mar;40(3):213-8. doi: 10.2340/16501977-0151. J Rehabil Med. 2008. PMID: 18292924 Free article.

8

Aerobic and resistance training in coronary disease: single versus multiple sets.

Marzolini S, Oh PI, Thomas SG, Goodman JM. Marzolini S, et al. Among authors: oh pi. Med Sci Sports Exerc. 2008 Sep;40(9):1557-64. doi: 10.1249/MSS.0b013e318177eb7f. Med Sci Sports Exerc. 2008. PMID: 18685538 Clinical Trial.

9

The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32-35 weeks: a Canadian-based analysis.

Lanctôt KL, Masoud ST, Paes BA, Tarride JE, Chiu A, Hui C, Francis PL, Oh PI. Lanctôt KL, et al. Among authors: oh pi. Curr Med Res Opin. 2008 Nov;24(11):3223-37. doi: 10.1185/03007990802484234. Epub 2008 Oct 16. Curr Med Res Opin. 2008. PMID: 18928643

10

Sex differences in completion of a 12-month cardiac rehabilitation programme: an analysis of 5922 women and men.

Marzolini S, Brooks D, Oh PI. Marzolini S, et al. Among authors: oh pi. Eur J Cardiovasc Prev Rehabil. 2008 Dec;15(6):698-703. doi: 10.1097/HJR.0b013e32830c1ce3. Eur J Cardiovasc Prev Rehabil. 2008. PMID: 18981927

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

270 results

Search Page

Filters